Try our Advanced Search for more refined results
Health
-
April 07, 2026
DC Circ. Skeptical Ex-Steward CEO Could Skip Senate Hearing
A D.C. Circuit judge told the attorney for the embattled former CEO of Steward Health Care on Tuesday that she couldn't comprehend how his client could invoke his Fifth Amendment rights without showing up to his scheduled appearance before a Senate committee.
-
April 07, 2026
BakerHostetler Adds Davis Wright Privacy Pro In LA
BakerHostetler announced Tuesday it has welcomed data privacy litigator Spencer Persson from Davis Wright Tremaine to its digital assets and data management practice group as partner, bringing in years of experience handling high-stakes privacy matters that will beef up the firm's privacy and digital risk class action and litigation team.
-
April 07, 2026
Jury Awards $39.5M Over Discharged Psych Patient's Victims
A Philadelphia jury on Tuesday hit a healthcare management company and a Pennsylvania hospital with a $39.5 million verdict, finding them liable for the deaths of four people who were murdered by a family member who was discharged from a psychiatric unit that failed to submit paperwork that would have prevented him from purchasing the gun he used to kill them.
-
April 07, 2026
5 Firms Advise On Gilead's Up To $5B Tubulis Acquisition
Gilead Sciences Inc. said Tuesday it has agreed to acquire German clinical-stage cancer biotechnology company Tubulis for up to $5 billion, in a deal steered by five law firms.
-
April 06, 2026
Florida Insurance Co. To Plead Guilty In $102.7M ACA Fraud
A Florida insurance company will plead guilty to defrauding the federal government out of more than $100 million in federal subsidies by targeting unhoused and other vulnerable people for enrollment in Affordable Care Act plans they did not qualify for, according to a notice filed Monday in Florida federal court.
-
April 06, 2026
RFK Jr. Tweaks HHS Vaccine Policy Panel Membership Criteria
U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. is making changes to a key federal vaccine advisory panel's charter, according to a renewal notice the agency published Monday, after a Massachusetts federal judge last month declared Kennedy's committee picks "appear distinctly unqualified."
-
April 06, 2026
Ore. Clinic Stuck With Privacy Suit Over LinkedIn Data Sharing
An Oregon federal judge has refused to throw out a putative class action accusing a fertility clinic of deploying tracking technology that illegally transmitted its website visitors' protected health information to LinkedIn for advertising purposes, finding that the plaintiff had adequately alleged that these disclosures violated federal health privacy law.
-
April 06, 2026
Canvassing Claims Are Moot After Definition Is Nixed, Fla. Says
Florida state officials are asking a federal judge to trim a lawsuit seeking to upend a state law imposing residency and citizenship restrictions on paid canvassers affiliated with some sponsors and supporters of ballot initiatives, saying the underlying law has been changed.
-
April 06, 2026
UMiami Can't Dodge Demoted Surgeon's Sex, Race Bias Suit
A Florida federal judge said Monday that the University of Miami can't fully escape a Latina surgeon's discrimination suit claiming she was demoted for reporting that her male colleagues were paid more, ruling she backed the core of her allegations with enough detail to keep her case in court.
-
April 06, 2026
3rd Circ. Backs Sentence Enhancement In $2M COVID Fraud
A man who was sentenced to more than 12 years in prison for defrauding pandemic-era safety-net programs of more than $2 million cannot challenge his sentence, a Third Circuit panel has ruled, finding he was a ringleader and thus qualified for a sentencing enhancement.
-
April 06, 2026
Feds Seek To Enforce Trans Healthcare Orders During Appeal
The Trump administration has asked the Fourth Circuit to let it enforce executive orders that ban federal funding for gender-affirming care for patients under age 19 while its appeal of a nationwide injunction is pending, arguing it's likely to succeed in its bid to overturn the trial court's order.
-
April 06, 2026
9th Circ. Panel Finds Insurer Owed Defense To Wash. Provider
An Allied World unit unreasonably declined to defend a Washington behavioral health network in a lawsuit alleging sexual misconduct by an employee, a Ninth Circuit panel held Monday, partially reversing a summary judgment win for the insurer.
-
April 06, 2026
Anthem Owes $2.1M For No Surprises Act Awards, Court Told
Two medical providers said Anthem Blue Cross and Blue Shield owes them a combined $2.1 million for medically necessary services rendered to its insured members, telling a Colorado state court that the carrier is wrongfully withholding payment despite losing multiple federal arbitration proceedings.
-
April 06, 2026
Biz Groups Urge 4th Circ. To End Allergan Overcharge Suit
Major pharmaceutical and business associations urged the Fourth Circuit to reconsider a panel decision that revived a whistleblower lawsuit accusing an Allergan Sales LLC predecessor of overcharging Medicaid, warning it threatens to become a road map for False Claims Act abuses.
-
April 06, 2026
Mich. Jury Awards $307M To Ex-Inmate Over Denied Surgery
A Michigan federal jury has awarded more than $300 million in a suit accusing a prison healthcare provider of refusing to approve a now former inmate's surgery, which forced him to defecate uncontrollably into a bag fastened to his stomach for more than two years.
-
April 06, 2026
Paperwork Lapse Led To 'Horrific' Family Slayings, Jury Told
Counsel for slain family members of a mentally ill man who murdered them after being discharged from a psychiatric ward asked a Philadelphia jury on Monday to impose a "substantial" verdict against a healthcare management company for allegedly not submitting paperwork that would have stopped him from buying a gun.
-
April 06, 2026
1st Circ. Suggests It May Resurrect AdTech Wiretap Case
A panel of the First Circuit appeared receptive Monday to reinstating federal wiretap claims leveled against a Massachusetts healthcare system over its use of online tracking tools, despite arguments that such a ruling could cripple the industry amid an influx of similar cases nationwide.
-
April 06, 2026
Full Fed. Circ. Urged To Course Correct On Design Patent Test
The full Federal Circuit needs to return design patent infringement to a similarities-focused test, rather than one looking at differences between designs, massage device-maker Range of Motion Products LLC said in a bid to revive its suit against Armaid Co.
-
April 06, 2026
Cleary FCA Task Force Head On Enforcement Trends To Watch
Former U.S. Attorney for the Eastern District of New York Breon Peace, who now leads a False Claims Act task force at Cleary Gottlieb Steen & Hamilton LLP, is predicting a continued surge in enforcement as the Trump administration wields the law in new ways.
-
April 06, 2026
NJ Pharmacy Co. Sued Over Nursing Home Data Exposure
A New Jersey pharmacy for long-term care facilities is facing a proposed nationwide class action alleging it failed to safeguard highly sensitive patient information later accessed by cybercriminals, according to a complaint filed in federal court.
-
April 06, 2026
Mass. Justices Hint Insurer Owes Defense In Doc's Discipline
An allegation that a Massachusetts doctor prescribed addictive medications to manipulate a patient into a sexual relationship could be enough to trigger a malpractice insurer's duty to defend him in a disciplinary proceeding launched years later over other alleged misconduct, justices on the state's highest court hinted Monday.
-
April 06, 2026
Pfizer Failed To Warn Of Depo-Provera Cancer Risk, Suit Says
A Georgia woman who alleged she developed a brain tumor after taking the contraceptive drug Depo-Provera sued Pfizer in federal court, claiming the company failed to warn American patients about the danger even though it does so on warning labels in the European Union.
-
April 06, 2026
WilmerHale Adds Regulatory Atty From Mayer Brown In DC
WilmerHale announced Monday it has hired a veteran U.S. Food and Drug Administration and life sciences regulatory attorney from Mayer Brown LLP.
-
April 06, 2026
Catching Up With Delaware's Chancery Court
The Delaware Chancery Court's docket this past week featured a mix of high-profile corporate disputes, insider trading allegations, contract fights and significant rulings shaping fiduciary duty and deal litigation.
-
April 06, 2026
Cooley, Wilson Sonsini Steer Neurocrine's $2.9B Soleno Buy
Neurocrine Biosciences has agreed to acquire biotechnology company Soleno Therapeutics for about $2.9 billion in cash, in a deal advised by Cooley LLP and Wilson Sonsini Goodrich & Rosati PC, the companies said on Monday.
Expert Analysis
-
Changes Coming To The SBIR And STTR Programs
Legislation recently approved by Congress to reauthorize the Small Business Innovation Research and Small Business Technology Transfer Programs includes changes focused on national security that would improve transparency but also increase applicants' administrative burdens, slow the awards process and likely increase litigation, say attorneys at Fluet & Associates.
-
FDA Framework For Personalized Therapies Raises Questions
The U.S. Food and Drug Administration's new plausible mechanism framework for developing individualized therapies reflects the agency's focus on rare-disease drugs, but numerous significant, unresolved issues cast uncertainty on how effective the framework will be in practice, say attorneys at Ropes & Gray.
-
5 Tips For Navigating Your Firm's All-Attorney Summit
Excerpt from Practical Guidance
Law firm retreats should be approached strategically, as they present valuable opportunities to advance both the firm's objectives and attorneys' professional development through meaningful participation, building and strengthening internal relationships, and proactive follow-up, says James Argionis at Cozen O’Connor.
-
Scrutiny Of Nursing Home Practices Marks Inflection Point
Recent congressional inquiries into UnitedHealth Group's Medicare Advantage-linked nursing home practices raise questions about whether financial metrics are allowed to influence decisions governed by the standard of care, and could implicate duties imposed by federal regulations, state negligence laws and elder abuse statutes, says Lindsey Gale at Rafferty Domnick.
-
Series
Coaching Soccer Makes Me A Better Lawyer
Coaching youth soccer for my 7-year-old son's team has sharpened how I communicate with clients, prepare witnesses, work within teams and think about leadership, making me a more thoughtful and effective lawyer in many ways, says Joshua Holt at Smith Currie.
-
Series
Law School's Missed Lessons: The Human Element
Law school teaches you to quickly apply intellect and logic when handling a legal issue, but every fact pattern also involves a person, making the ability to balance expertise with empathy critical to the growth of relationships with clients, colleagues and adversaries, says Rachel Adcox at Adcox Strategies.
-
CMS Healthcare Enforcement Initiatives May Cause Disruption
The Centers for Medicare & Medicaid Services' recently announced enforcement actions against healthcare fraud mark a significant escalation, and CMS' prior approach in the hospice sector suggests that even compliant providers and suppliers should brace for impact, say attorneys at Morgan Lewis.
-
How Cos. Should Prepare For NY RAISE Act Compliance
With the New York Responsible AI Safety and Education Act taking effect March 19, state regulators will expect subject artificial intelligence governance policies to understand whether appropriate safeguards and protocols are in place to prevent or mitigate discriminatory or adverse outcomes by frontier models, says Michael Paulino at Gordon Rees.
-
What We Know About DOJ's New FCA Enforcement Priorities
Recent remarks from the leader of the Justice Department’s commercial litigation branch provide key insights on how False Claims Act cases — especially healthcare fraud, trade fraud, antidiscrimination and cybersecurity claims — will be evaluated, prioritized and pursued as heightened enforcement becomes the new normal, say attorneys at Latham.
-
The Benefits Of Choosing A Niche Practice In The AI Age
As artificial intelligence becomes increasingly accessible, lawyers with a niche practice may stand out as clients seek specialized judgment that automation cannot replicate, but it is important to choose a niche that is durable, engaging and a good personal fit, says Daniel Borneman at Lowenstein Sandler.
-
How PBMs Can Adapt To Plan Sponsors' Disclosure Demands
As federal reforms, growing state regulation and litigation threats push plan sponsors to expect visibility into revenue streams, pharmacy benefit managers should leverage transparency strategically, including by simplifying how they get paid, offering clients audit-ready data and co-designing contracts that are easy for fiduciaries to explain and defend, says Kristie Blase at Frazer + Blase.
-
How To Engage With Gov't's Direct-To-Consumer Drug Policy
The U.S. Department of Health and Human Services' recent request for industry input on manufacturers' direct-to-consumer drug sales reflects the government's caution in this arena, and allows stakeholders a rare opportunity to help shape policy, says Mary Kohler at Kohler Health Law.
-
Opinion
It's Time To Clarify California's Elder Abuse Act
As California's elderly population soars, the Golden State's high court and Legislature must provide needed clarification about the scope of the Elder Abuse Act, to resolve the inconsistencies and ambiguities that have impeded the law's ability to remedy elder abuse, neglect and abandonment, say attorneys at Horvitz & Levy.
-
Series
Podcasting Makes Me A Better Lawyer
Podcasting has changed how I ask questions and connect with people, sharpening my ability to listen without interrupting or prejudging, and bringing me closer to what law is meant to be: a human profession grounded in understanding, judgment and trust, says Donna DiMaggio Berger at Becker.
-
When Fraud Involvement Disqualifies FCA Whistleblowers
A Massachusetts federal court's recent dismissal of a False Claims Act relator in U.S. ex rel. Perry v. First Psychiatric Planners provides instructive insight into when whistleblowers may be denied their share of settlement proceeds, even if their involvement in the underlying fraud is a step removed, say attorneys at Holland & Knight.